Anterogen.Co.,Ltd. (065660.KQ)
KRW 16060.0
(-6.3%)
KRW 16060.0
(-6.3%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.91 Billion KRW | -4.86% |
| 2022 | 2 Billion KRW | 57.01% |
| 2021 | 1.27 Billion KRW | -42.11% |
| 2020 | 2.2 Billion KRW | 61.52% |
| 2019 | 1.36 Billion KRW | 64.64% |
| 2018 | 830.72 Million KRW | 49.98% |
| 2017 | 553.9 Million KRW | 31.6% |
| 2016 | 420.88 Million KRW | 31.31% |
| 2015 | 320.52 Million KRW | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 1.47 Billion KRW | -22.79% |
| 2024 Q2 | 1.01 Billion KRW | -31.42% |
| 2023 Q2 | 2.1 Billion KRW | 21.41% |
| 2023 Q4 | 1.91 Billion KRW | -9.68% |
| 2023 FY | 1.91 Billion KRW | -4.86% |
| 2023 Q1 | 1.73 Billion KRW | -13.52% |
| 2023 Q3 | 2.11 Billion KRW | 0.33% |
| 2022 FY | 2 Billion KRW | 57.01% |
| 2022 Q4 | 2 Billion KRW | 39.39% |
| 2022 Q3 | 1.44 Billion KRW | -9.65% |
| 2022 Q1 | 1.71 Billion KRW | 33.74% |
| 2022 Q2 | 1.59 Billion KRW | -6.78% |
| 2021 Q4 | 1.27 Billion KRW | -1.83% |
| 2021 FY | 1.27 Billion KRW | -42.11% |
| 2021 Q3 | 1.3 Billion KRW | -6.97% |
| 2021 Q1 | 1.56 Billion KRW | -29.15% |
| 2021 Q2 | 1.4 Billion KRW | -10.54% |
| 2020 Q2 | 1.51 Billion KRW | -29.62% |
| 2020 Q3 | 2.22 Billion KRW | 47.35% |
| 2020 Q4 | 2.2 Billion KRW | -0.74% |
| 2020 FY | 2.2 Billion KRW | 61.52% |
| 2020 Q1 | 2.14 Billion KRW | 56.92% |
| 2019 Q3 | 680.76 Million KRW | -27.72% |
| 2019 Q2 | 941.81 Million KRW | 4.03% |
| 2019 Q1 | 905.36 Million KRW | 8.99% |
| 2019 FY | 1.36 Billion KRW | 64.64% |
| 2019 Q4 | 1.36 Billion KRW | 100.91% |
| 2018 Q3 | 687.35 Million KRW | -1.2% |
| 2018 Q4 | 830.72 Million KRW | 20.86% |
| 2018 FY | 830.72 Million KRW | 49.98% |
| 2018 Q1 | 607.74 Million KRW | 9.72% |
| 2018 Q2 | 695.72 Million KRW | 14.48% |
| 2017 Q3 | 458.14 Million KRW | -4.03% |
| 2017 Q1 | 463.17 Million KRW | 10.05% |
| 2017 Q2 | 477.4 Million KRW | 3.07% |
| 2017 Q4 | 553.9 Million KRW | 20.9% |
| 2017 FY | 553.9 Million KRW | 31.6% |
| 2016 FY | 420.88 Million KRW | 31.31% |
| 2016 Q1 | 267.06 Million KRW | -16.68% |
| 2016 Q2 | 675.52 Million KRW | 152.95% |
| 2016 Q4 | 420.88 Million KRW | -12.23% |
| 2016 Q3 | 479.52 Million KRW | -29.01% |
| 2015 Q4 | 320.52 Million KRW | 0.0% |
| 2015 FY | 320.52 Million KRW | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| HLB Co., Ltd. | 11.42 Billion KRW | 83.273% |
| iNtRON Biotechnology, Inc. | 1.01 Billion KRW | -88.952% |
| BINEX Co., Ltd. | 28.26 Billion KRW | 93.24% |
| Bioneer Corporation | 41.35 Billion KRW | 95.38% |
| MEDIPOST Co., Ltd. | 14.51 Billion KRW | 86.839% |
| CrystalGenomics, Inc. | 1.55 Billion USD | -22.879% |
| Helixmith Co., Ltd | 914.11 Million KRW | -109.001% |
| Chabiotech Co.,Ltd. | 34.11 Billion KRW | 94.4% |
| Medy-Tox Inc. | 59.61 Billion KRW | 96.795% |
| Peptron, Inc. | 172.18 Million KRW | -1009.55% |
| Amicogen, Inc. | 46.83 Billion KRW | 95.921% |
| Genexine, Inc. | 3.8 Billion KRW | 49.815% |
| HLB Therapeutics Co.,Ltd. | 5.33 Billion KRW | 64.195% |
| LegoChem Biosciences, Inc. | 196.83 Million KRW | -870.616% |
| ALTEOGEN Inc. | 1.06 Billion KRW | -78.826% |
| PharmaResearch Co., Ltd. | 50.23 Billion KRW | 96.197% |
| SillaJen, Inc. | 1.21 Billion KRW | -57.551% |
| JETEMA, Co., Ltd. | 12.74 Billion KRW | 85.005% |
| OliX Pharmaceuticals,Inc | 468.4 Million KRW | -307.871% |
| Genomictree Inc. | 496.53 Million KRW | -284.77% |
| MedPacto, Inc. | 620.00 KRW | -308145913.065% |
| D&D Pharmatech | 3.45 Billion KRW | 44.627% |
| EASY BIO,Inc. | 25.93 Billion KRW | 92.635% |
| GI Innovation, Inc. | - KRW | -Infinity% |